4/12/2017 Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Los Angeles, California: April 28, 2017 Learning Objectives After attending this presentation, learners will be able to: Diagnose and manage gonorrhea List treatment options for chlamydia Describe manifestations of syphilis Slide 3 of 36 Case 28 year old man with urethral discharge Slide 4 of 36 Los Angeles, California: April 28, 2017 1 4/12/2017 Differential Diagnosis of Urethritis Infectious Neisseria gonorrhoeae Chlamydia trachomatis Mycoplasma genitalium Trichomonas vaginalis Herpes simplex virus 1 and 2 Oral flora---streptococci, anaerobes, haemophilus Non-infectious Trauma—physical, chemical, sex-play related Autoimmune—Reactive arthritis Slide 5 of 36 Uncomplicated gonococcal infection Neisseria gonorrhoeae Urethra Cervix Pharynx Rectum Gram-negative intracellular diplococci Slide 6 of 36 Detection of N. gonorrhoeae infection Sensitivity Gram stain Specificity 92% 90% Culture 95% 100% DNA/RNA amplification* 95% 99% *May be used on clinician- or self-collected vaginal, cervical, rectal, pharyngeal specimens and urine Slide 7 of 36 Los Angeles, California: April 28, 2017 2 4/12/2017 Gonorrhea — Rates of Reported Cases by Race/Ethnicity, United States, 2011–2015 * AI/AN = American Indians/Alaska Natives; NHOPI = Native Hawaiian/Other Pacific Islanders. Susceptibility changes of Neisseria gonorrhoeae to cefixime and ceftriaxone Multi-drug treatment for gonorrhea Ceftriaxone 250 mg IM once Azithromycin 1 gm PO once Plus partner treatment Retesting at 3 months Slide 10 of 36 Los Angeles, California: April 28, 2017 3 4/12/2017 Slide 11 of 36 CID, 2017 Case 28 year old HIV-infected male here for a check-up. He has one regular partner and occasional partners he meets at various venues, clubs He has no symptoms What STD screening tests are appropriate? Slide 13 of 36 Los Angeles, California: April 28, 2017 4 4/12/2017 STI screening in Men who have Sex with Men Chlamydia trachomatis/ Neisseria gonorrhoeae – throat, rectum, urine Syphilis (Treponemal then RPR) Avoid – Anal PAP smear – Routine HSV-1/2 antibody testing US CDC 2015; USPSTF, 2013 Slide 14 of 36 Test results Throat – CT/NG negative Urine – CT/NG negative Rectum – CT positive, NG negative Blood – TPPA positive, RPR negative Slide 15 of 36 Case Case 44 year old man with new lesion near his anus Slide 18 of 36 Los Angeles, California: April 28, 2017 5 4/12/2017 Differential diagnosis of genital ulcer STDs Other Genital herpes Fixed drug reactions Primary syphilis Staph/strep Chancroid Autoimmune Slide 19 of 36 Treponema pallidum pallidum, bacterial spirochete Slide 20 of 36 Primary syphilis – penile chancres Slide 21 of 36 Los Angeles, California: April 28, 2017 6 4/12/2017 Secondary syphilis: trunk rash Slide 22 of 36 Secondary syphilis: palmar and plantar lesions Slide 23 of 36 Slide 24 of 36 Los Angeles, California: April 28, 2017 7 4/12/2017 Slide 25 of 36 Secondary syphilis: split papules, “moth-eaten” alopecia, mucous patches and condyloma lata J. Engelman Split papule (mucous patch) Katz www.merckmedicus.com Moth-eaten alopecia Condyloma lata Mucous patch J. Engelman Katz Klausner Slide 26 of 36 Latent syphilis This page intentionally left blank! Slide 27 of 36 Los Angeles, California: April 28, 2017 8 4/12/2017 Those syphilis tests Non-treponemal tests (RPR, VDRL) – – – – Antibody to cardiolipin-lecithin-phospholipids Rise and fall with infection and treatment over time 4-fold change in titer (1:2 to 1:8 or 1:64 to 1:16) is significant Specificity = 98% (false-positives in IDU, auto-immune, etc) Treponemal tests (FTA-Abs, TPPA, TP EIA) – – – – Antibody to Treponemal antigen More sensitive and develop earlier Stay positive for “life” (85%) Indicate past or current infection Klausner, Current STD Diagnosis and Management 2007 Slide 28 of 36 Injectable penicillin is treatment of choice for early syphilis • Single intramuscular injection 2.4 MU benzathine penicillin • Prophylactic treatment: • Syphilis case contacts < 90 days • Doxycycline chemoprophylaxis Slide 29 of 36 Syphilis — Rates of Reported Cases by Stage of Infection, United States, 1941–2015 NOTE: Data collection for syphilis began in 1941; however, syphilis became nationally notifiable in 1944. Refer to the National Notifiable Disease Surveillance System (NNDSS) website for more information: https://wwwn.cdc.gov/nndss/conditions/syphilis/. Los Angeles, California: April 28, 2017 9 4/12/2017 Slide 31 of 36 CDC recommended indications for lumbar puncture 1) Neurologic symptoms or signs 2) Suspected ocular syphilis 3) Treatment failure 4) Tertiary syphilis HIV infection, immunosuppression or elevated RPR titer while associated with increased risk for neurosyphilis are not indications for CSF analysis Slide 33 of 36 Slide 34 of 36 Los Angeles, California: April 28, 2017 10 4/12/2017 Sources for more STD information CDC – www.cdc.gov/std Current STD Textbook Slide 35 of 36 Thank you Slide 36 of 36 Los Angeles, California: April 28, 2017 11 Dr Klausner Suggested Readings Activity #: HIV 17 LA (F) 04-26-17 Page: 1 SUGGESTED READINGS 1.Kojima N, Davey DJ, Klausner JD. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS. 2016;30(14):2251-2252. Ref ID: 15053 2. Scott HM, Klausner JD. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Res Ther. 2016;13:5. Ref ID: 15054 3. Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis. 2015;42(2):98-103. Ref ID: 15055 4. Andrade R, Rodriguez-Barradas MC, Yasukawa K, Villarreal E, Ross M, Serpa JA. Single dose versus 3 Doses of intramuscular benzathine penicillin for early syphilis in HIV: a randomized clinical trial. Clin Infect Dis. 2017;64(6):759-764. Ref ID: 15056 5. de Voux A, Kidd S, Grey JA, et al. State-specific rates of primary and secondary syphilis among men who have sex with men - United States, 2015. Morb Mortal Wkly Rep. 2017;66(13):349-354. Ref ID: 15057 6. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004;18(15):2075-2079. Ref ID: 11444 7. Steedman NM, McMillan A. Treatment of asymptomatic rectal Chlamydia trachomatis: is single-dose azithromycin effective? Int J STD AIDS. 2009;20(1):16-18. Ref ID: 15061 8. Hathorn E, Opie C, Goold P. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women? Sex Transm Infect. 2012;88(5):352-354. Ref ID: 15058 9. Kong FY, Tabrizi SN, Fairley CK, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70(5):1290-1297. Ref ID: 14672 10. Allan-Blitz LT, Wang X, Klausner JD. Wild-type gyrase A genotype of Neisseria gonorrhoeae predicts in vitro susceptibility to ciprofloxacin: a systematic review of the literature and meta-analysis. Sex Transm Dis. 2017;44(5):261-265. Dr Klausner Suggested Readings Activity #: HIV 17 LA (F) 04-26-17 Page: 2 Ref ID: 15059 11. Allan-Blitz LT, Humphries RM, Hemarajata P, et al. Implementation of a rapid genotypic assay to promote targeted ciprofloxacin therapy of Neisseria gonorrhoeae in a large health system. Clin Infect Dis. 2017;64(9):1268-1270. Ref ID: 15060
© Copyright 2026 Paperzz